Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Claudia Kiesecker is active.

Publication


Featured researches published by Claudia Kiesecker.


Circulation | 2005

QTc Prolongation by Grapefruit Juice and Its Potential Pharmacological Basis HERG Channel Blockade by Flavonoids

Edgar Zitron; Eberhard P. Scholz; Robert W. Owen; Sonja Lück; Claudia Kiesecker; Dierk Thomas; Sven Kathöfer; Feraydoon Niroomand; Johann Kiehn; Volker A. W. Kreye; Hugo A. Katus; Wolfgang Schoels; Christoph A. Karle

Background—A high intake of dietary flavonoids, which are abundant in fruits, vegetables, tea, and wine, is known to reduce cardiovascular mortality. The effects of flavonoids on cardiac electrophysiology, which theoretically may have both antiarrhythmic and proarrhythmic consequences, have not been studied systematically to date. Methods and Results—We screened a broad spectrum of flavonoids for their inhibitory activity on HERG channels by using heterologous expression in Xenopus oocytes. At a concentration of 1 mmol/L, 10 compounds caused a significant inhibition of HERG currents, whereas 11 other flavonoids had no effect. The IC50 value for HERG block by naringenin, the most potent inhibitor, was 102.3 &mgr;mol/L in Xenopus oocytes and 36.5 &mgr;mol/L in HEK cells. To demonstrate the physiological relevance of these findings, we studied the effects of pink grapefruit juice, which contains large amounts of naringenin glycosides (>1000 &mgr;mol/L), in human volunteers. In 10 persons, we observed a peak QTc prolongation of 12.5±4.2 ms 5 hours after oral ingestion of 1 L of grapefruit juice. This effect was significant (P=0.02). Conclusions—We found a significant QTc prolongation by grapefruit juice in healthy volunteers, probably caused by block of HERG channels by flavonoids. These findings reveal new perspectives on the potential for dietary modification of cardiac electrophysiology.


British Journal of Pharmacology | 2009

Regulation of two-pore-domain (K2P) potassium leak channels by the tyrosine kinase inhibitor genistein

Jakob Gierten; Eckhard Ficker; Ramona Bloehs; K Schlömer; Sven Kathöfer; Eberhard P. Scholz; Edgar Zitron; Claudia Kiesecker; Alexander Bauer; Rüdiger Becker; Hugo A. Katus; Christoph A. Karle; Dierk Thomas

Two‐pore‐domain potassium (K2P) channels mediate potassium background (or ‘leak’) currents, controlling excitability by stabilizing membrane potential below firing threshold and expediting repolarization. Inhibition of K2P currents permits membrane potential depolarization and excitation. As expected for key regulators of excitability, leak channels are under tight control from a plethora of stimuli. Recently, signalling via protein tyrosine kinases (TKs) has been implicated in ion channel modulation. The objective of this study was to investigate TK regulation of K2P channels.


Journal of Molecular Medicine | 2006

Regulation of cardiac inwardly rectifying potassium current Ik1 and Kir2.x channels by endothelin-1

Claudia Kiesecker; Edgar Zitron; Daniel Scherer; Sonja Lueck; Ramona Bloehs; Eberhard P. Scholz; Marcus Pirot; Sven Kathöfer; Dierk Thomas; Volker A. W. Kreye; Johann Kiehn; Mathias M. Borst; Hugo A. Katus; Wolfgang Schoels; Christoph A. Karle

To elucidate the ionic mechanism of endothelin-1 (ET-1)-induced focal ventricular tachyarrhythmias, the regulation of IK1 and its main molecular correlates, Kir2.1, Kir2.2 and Kir2.3 channels, by ET-1 was investigated. Native IK1 in human atrial cardiomyocytes was studied with whole-cell patch clamp. Human endothelin receptors were coexpressed with human Kir2.1, Kir2.2 and Kir2.3 channels in Xenopus oocytes. Currents were measured with a two-microelectrode voltage clamp. In human cardiomyocytes, ET-1 induced a marked inhibition of IK1 that could be suppressed by the protein kinase C (PKC) inhibitor staurosporine. To investigate the molecular mechanisms underlying this regulation, we studied the coupling of ETA receptors to homomeric and heteromeric Kir2.1, Kir2.2 and Kir2.3 channels in the Xenopus oocyte expression system. ETA receptors coupled functionally to Kir2.2 and Kir2.3 channels but not to Kir2.1 channels. In Kir2.2 channels lacking functional PKC phosphorylation sites, the inhibitory effect was abolished. The inhibition of Kir2.3 currents could be suppressed by the PKC inhibitors staurosporine and chelerythrine. The coupling of ETA receptors to heteromeric Kir2.1/Kir2.2 and Kir2.2/Kir2.3 channels resulted in a strong inhibition of currents comparable with the effect observed in Kir2.2 homomers. Surprisingly, in heteromeric Kir2.1/Kir2.3 channels, no effect was observed. ET-1 inhibits human cardiac IK1 current via a PKC-mediated phosphorylation of Kir2.2 channel subunits and additional regulatory effects on Kir2.3 channels. This mechanism may contribute to the intrinsic arrhythmogenic potential of ET-1.


Journal of the American College of Cardiology | 2004

807-2 Selective inhibition of human cardiac Kir2.2 inward rectifier channels by adrenergic alpha-1a receptors

Edgar Zitron; Claudia Kiesecker; Sonja Lück; Eberhard P. Scholz; Dierk Thomas; Sven Kathöfer; Volker A. W. Kreye; Wolfgang Schoels; Hugo A. Katus; Christoph A. Karle

Ca rd ia c Ar rh yt hm ia s (N588K) in the pore forming region of the cardiac Kr channel (KCNH2, HERG). The mutations dramatically increase IKr leading to heterogeneous abbreviation of action potential duration and refractoriness and rendering the channel relatively unresponsive to IKr blockers. Conclusion: Our data point to a novel genetic mechanism responsible for sudden death in children, infants and young adults. The mutation leads to a heterogeneous abbreviation of action potential duration and refractoriness, creating the substrate for reentrant arrhythmias.


Naunyn-schmiedebergs Archives of Pharmacology | 2003

Drug binding to aromatic residues in the HERG channel pore cavity as possible explanation for acquired Long QT syndrome by antiparkinsonian drug budipine

Eberhard P. Scholz; Edgar Zitron; Claudia Kiesecker; Sonja Lueck; Sven Kathöfer; Dierk Thomas; Slawomir Weretka; Simon Peth; Volker A. W. Kreye; Wolfgang Schoels; Hugo A. Katus; Johann Kiehn; Christoph A. Karle


Naunyn-schmiedebergs Archives of Pharmacology | 2004

Inhibition of cardiac HERG potassium channels by the atypical antidepressant trazodone

Edgar Zitron; Claudia Kiesecker; Eberhard P. Scholz; Sonja Lück; Ramona Bloehs; Sven Kathöfer; Dierk Thomas; Johann Kiehn; Volker A. W. Kreye; Hugo A. Katus; Wolfgang Schoels; Christoph A. Karle


Naunyn-schmiedebergs Archives of Pharmacology | 2004

Class Ia anti-arrhythmic drug ajmaline blocks HERG potassium channels: mode of action

Claudia Kiesecker; Edgar Zitron; Sonja Lück; Ramona Bloehs; Eberhard P. Scholz; Sven Kathöfer; Dierk Thomas; Volker A. W. Kreye; Hugo A. Katus; Wolfgang Schoels; Christoph A. Karle; Johann Kiehn


Cardiovascular Research | 2004

Human cardiac inwardly rectifying current IKir2.2 is upregulated by activation of protein kinase A

Edgar Zitron; Claudia Kiesecker; Sonja Lück; Sven Kathöfer; Dierk Thomas; Volker A. W. Kreye; Johann Kiehn; Hugo A. Katus; Wolfgang Schoels; Christoph A. Karle


Nutrition Metabolism and Cardiovascular Diseases | 2007

Orange flavonoid hesperetin modulates cardiac hERG potassium channel via binding to amino acid F656

Eberhard P. Scholz; Edgar Zitron; Claudia Kiesecker; Dierk Thomas; Sven Kathöfer; Jörg Kreuzer; Alexander Bauer; Hugo A. Katus; Andrew Remppis; Christoph A. Karle; Johannes Greten


Biochemical and Biophysical Research Communications | 2007

Green tea flavonoid epigallocatechin-3-gallate (EGCG) inhibits cardiac hERG potassium channels.

Kamilla Kelemen; Claudia Kiesecker; Edgar Zitron; Alexander Bauer; Eberhard P. Scholz; Ramona Bloehs; Dierk Thomas; Johannes Greten; Andrew Remppis; Wolfgang Schoels; Hugo A. Katus; Christoph A. Karle

Collaboration


Dive into the Claudia Kiesecker's collaboration.

Top Co-Authors

Avatar

Christoph A. Karle

University Hospital Heidelberg

View shared research outputs
Top Co-Authors

Avatar

Edgar Zitron

University Hospital Heidelberg

View shared research outputs
Top Co-Authors

Avatar

Sven Kathöfer

University Hospital Heidelberg

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Eberhard P. Scholz

University Hospital Heidelberg

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ramona Bloehs

University Hospital Heidelberg

View shared research outputs
Top Co-Authors

Avatar

Johann Kiehn

University Hospital Heidelberg

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge